CCDC170 Antikörper (AA 451-550) (FITC)

Produktnummer ABIN1710683

Produktdetails anti-CCDC170 Antikörper (FITC)

Target: CCDC170 (Coiled-Coil Domain Containing 170 (CCDC170))

Bindungsspezifität: AA 451-550

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser CCDC170 Antikörper ist konjugiert mit FITC

Applikation: Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Homologie: Human,Mouse,Rat,Cow,Pig,Horse

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human C6orf97

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Haltbarkeit: 12 months

Details zu CCDC170

Target: CCDC170 (Coiled-Coil Domain Containing 170 (CCDC170))

Andere Bezeichnung: C6orf97 (CCDC170 Produkte)

Synonyme: C6orf97 antikoerper, bA282P11.1 antikoerper, RGD1310945 antikoerper, coiled-coil domain containing 170 antikoerper, CCDC170 antikoerper, Ccdc170 antikoerper

Hintergrund:

Synonyms: bA282P11.1, C6orf97, CC170_HUMAN, Chromosome 6 open reading frame 97, Coiled coil domain containing protein C6orf97, Coiled-coil domain-containing protein C6orf97, FLJ23305, Hypothetical protein LOC80129, LOC80129.

Background: Making up nearly 6 % of the human genome, chromosome 6 contains around 1,200 genes within 170 million base pairs of sequence. Deletion of a portion of the q arm of chromosome 6 is associated with early onset intestinal cancer suggesting the presence of a cancer susceptibility locus. Porphyria cutanea tarda is associated with chromosome 6 through the HFE gene which, when mutated, predisposes an individual to developing this porphyria. Notably, the PARK2 gene, which is associated with Parkinson's disease, and the genes encoding the major histocompatiblity complex proteins, which are key molecular components of the immune system and determine predisposition to rheumatic diseases, are also located on chromosome 6. Stickler syndrome, 21-hydroxylase deficiency and maple syrup urine disease are also associated with genes on chromosome 6. A bipolar disorder susceptibility locus has been identified on the q arm of chromosome 6. The C6orf97 gene product has been provisionally designated C6orf97 pending further characterization.

Gen-ID: 80129